Core Laboratories (NYSE:CLB) Updates Q1 2026 Earnings Guidance

Core Laboratories (NYSE:CLB) issued an update on its first quarter 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.050-0.070 for the period, compared to the consensus earnings per share estimate of 0.160. The company issued revenue guidance of $119.0 million-$123.0 million, compared to the consensus revenue estimate of $127.2 million.

Core Laboratories Stock Performance

Shares of NYSE CLB opened at $16.67 on Friday. The stock has a market cap of $767.39 million, a price-to-earnings ratio of 24.87, a P/E/G ratio of 14.62 and a beta of 1.15. The company has a current ratio of 2.02, a quick ratio of 1.51 and a debt-to-equity ratio of 0.41. Core Laboratories has a 1-year low of $9.72 and a 1-year high of $20.36. The stock’s 50-day moving average is $17.32 and its 200 day moving average is $16.20.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.01. The company had revenue of $138.26 million for the quarter, compared to analysts’ expectations of $130.40 million. Core Laboratories had a return on equity of 12.18% and a net margin of 6.04%.Core Laboratories’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period last year, the firm posted $0.22 EPS. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. On average, sell-side analysts anticipate that Core Laboratories will post 0.96 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 9th. Investors of record on Monday, February 16th were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, February 13th. Core Laboratories’s dividend payout ratio (DPR) is currently 5.97%.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Core Laboratories in a report on Friday, March 27th. Four analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $12.50.

Hedge Funds Weigh In On Core Laboratories

A number of large investors have recently bought and sold shares of the stock. Corient Private Wealth LLC purchased a new position in Core Laboratories in the 4th quarter worth approximately $219,000. T. Rowe Price Investment Management Inc. grew its position in shares of Core Laboratories by 14.8% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 1,042,208 shares of the oil and gas company’s stock worth $16,707,000 after buying an additional 134,050 shares during the last quarter. XTX Topco Ltd grew its position in shares of Core Laboratories by 110.9% in the 4th quarter. XTX Topco Ltd now owns 54,273 shares of the oil and gas company’s stock worth $870,000 after buying an additional 28,541 shares during the last quarter. Old West Investment Management LLC bought a new stake in shares of Core Laboratories in the 4th quarter worth approximately $613,000. Finally, AQR Capital Management LLC grew its position in shares of Core Laboratories by 32.6% in the 4th quarter. AQR Capital Management LLC now owns 49,818 shares of the oil and gas company’s stock worth $799,000 after buying an additional 12,242 shares during the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.